634 related articles for article (PubMed ID: 18594945)
1. A role for anti-transglutaminase 2 autoantibodies in the pathogenesis of coeliac disease?
Lindfors K; Kaukinen K; Mäki M
Amino Acids; 2009 Apr; 36(4):685-91. PubMed ID: 18594945
[TBL] [Abstract][Full Text] [Related]
2. Tissue transglutaminase in celiac disease: role of autoantibodies.
Caputo I; Barone MV; Martucciello S; Lepretti M; Esposito C
Amino Acids; 2009 Apr; 36(4):693-9. PubMed ID: 18600381
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
Lindfors K; Mäki M; Kaukinen K
Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
[TBL] [Abstract][Full Text] [Related]
4. Gluten-dependent small bowel mucosal transglutaminase 2-specific IgA deposits in overt and mild enteropathy coeliac disease.
Koskinen O; Collin P; Korponay-Szabo I; Salmi T; Iltanen S; Haimila K; Partanen J; Mäki M; Kaukinen K
J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):436-42. PubMed ID: 18852635
[TBL] [Abstract][Full Text] [Related]
5. Altered small-bowel mucosal vascular network in untreated coeliac disease.
Myrsky E; Syrjänen M; Korponay-Szabo IR; Mäki M; Kaukinen K; Lindfors K
Scand J Gastroenterol; 2009; 44(2):162-7. PubMed ID: 18985542
[TBL] [Abstract][Full Text] [Related]
6. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study.
Kaukinen K; Peräaho M; Collin P; Partanen J; Woolley N; Kaartinen T; Nuutinen T; Halttunen T; Mäki M; Korponay-Szabo I
Scand J Gastroenterol; 2005 May; 40(5):564-72. PubMed ID: 16036509
[TBL] [Abstract][Full Text] [Related]
7. Intestinal transglutaminase 2 specific antibody deposits in non-responsive coeliac disease.
Koskinen O; Lindfors K; Collin P; Peräaho M; Laurila K; Woolley N; Partanen J; Mäki M; Kaukinen K
Dig Liver Dis; 2010 Oct; 42(10):692-7. PubMed ID: 20409763
[TBL] [Abstract][Full Text] [Related]
8. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits.
Salmi TT; Collin P; Korponay-Szabó IR; Laurila K; Partanen J; Huhtala H; Király R; Lorand L; Reunala T; Mäki M; Kaukinen K
Gut; 2006 Dec; 55(12):1746-53. PubMed ID: 16571636
[TBL] [Abstract][Full Text] [Related]
9. Transglutaminase 2-specific coeliac disease autoantibodies induce morphological changes and signs of inflammation in the small-bowel mucosa of mice.
Kalliokoski S; Piqueras VO; Frías R; Sulic AM; Määttä JA; Kähkönen N; Viiri K; Huhtala H; Pasternack A; Laurila K; Sblattero D; Korponay-Szabó IR; Mäki M; Caja S; Kaukinen K; Lindfors K
Amino Acids; 2017 Mar; 49(3):529-540. PubMed ID: 27503559
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of small-bowel mucosal transglutaminase-2 specific autoantibody deposits in the diagnosis and follow-up of celiac disease.
Koskinen O; Collin P; Lindfors K; Laurila K; Mäki M; Kaukinen K
J Clin Gastroenterol; 2010 Aug; 44(7):483-8. PubMed ID: 19779364
[TBL] [Abstract][Full Text] [Related]
11. The role of the immune response against tissue transglutaminase in the pathogenesis of coeliac disease.
Freitag T; Schulze-Koops H; Niedobitek G; Melino G; Schuppan D
Autoimmun Rev; 2004 Feb; 3(2):13-20. PubMed ID: 15003183
[TBL] [Abstract][Full Text] [Related]
12. Oats do not induce systemic or mucosal autoantibody response in children with coeliac disease.
Koskinen O; Villanen M; Korponay-Szabo I; Lindfors K; Mäki M; Kaukinen K
J Pediatr Gastroenterol Nutr; 2009 May; 48(5):559-65. PubMed ID: 19412007
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies in celiac disease.
Alaedini A; Green PH
Autoimmunity; 2008 Feb; 41(1):19-26. PubMed ID: 18176861
[TBL] [Abstract][Full Text] [Related]
14. Celiac disease: epidemiology, pathogenesis, diagnosis, and nutritional management.
Schuppan D; Dennis MD; Kelly CP
Nutr Clin Care; 2005; 8(2):54-69. PubMed ID: 16013224
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to recombinant human tissue-transglutaminase in coeliac disease: diagnostic effectiveness and decline pattern after gluten-free diet.
Bazzigaluppi E; Roggero P; Parma B; Brambillasca MF; Meroni F; Mora S; Bosi E; Barera G
Dig Liver Dis; 2006 Feb; 38(2):98-102. PubMed ID: 16386476
[TBL] [Abstract][Full Text] [Related]
16. Detection of anti-endomysial and anti-tissue transglutaminase autoantibodies in media following culture of oral biopsies from patients with untreated coeliac disease.
Vetrano S; Zampaletta U; Anania MC; Di Tola M; Sabbatella L; Passarelli F; Maffia C; Sanjust MG; Lettieri F; De Pità O; Picarelli A
Dig Liver Dis; 2007 Oct; 39(10):911-6. PubMed ID: 17719860
[TBL] [Abstract][Full Text] [Related]
17. Immunological effects of transglutaminase-treated gluten in coeliac disease.
Elli L; Roncoroni L; Hils M; Pasternack R; Barisani D; Terrani C; Vaira V; Ferrero S; Bardella MT
Hum Immunol; 2012 Oct; 73(10):992-7. PubMed ID: 22836039
[TBL] [Abstract][Full Text] [Related]
18. Are xenogeneic anti-tissue transglutaminase antibodies the holy grail for celiac patients?
Ivanovski PI; Ivanovski IP; Sedlarevic R
Med Hypotheses; 2007; 69(6):1257-60. PubMed ID: 17553630
[TBL] [Abstract][Full Text] [Related]
19. Presence of anti-"tissue" transglutaminase antibodies in inflammatory intestinal diseases: an apoptosis-associated event?
Farrace MG; Picarelli A; Di Tola M; Sabbatella L; Marchione OP; Ippolito G; Piacentini M
Cell Death Differ; 2001 Jul; 8(7):767-70. PubMed ID: 11464221
[No Abstract] [Full Text] [Related]
20. Anti-idiotypic response in mice expressing human autoantibodies.
Di Niro R; Sblattero D; Florian F; Stebel M; Zentilin L; Giacca M; Villanacci V; Galletti A; Not T; Ventura A; Marzari R
Mol Immunol; 2008 Mar; 45(6):1782-91. PubMed ID: 17996305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
